A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
- PMID: 19219043
- PMCID: PMC4509508
- DOI: 10.1038/ng.317
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
Erratum in
- Nat Genet. 2010 May;42(5):464
Retraction in
-
Retraction: A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.Nat Genet. 2016 Feb;48(2):221. doi: 10.1038/ng0216-221. Nat Genet. 2016. PMID: 26813765 Free PMC article. No abstract available.
Abstract
microRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by targeting messenger RNA (mRNA) transcripts. Recently, a miRNA expression profile of human tumors has been characterized by an overall miRNA downregulation. Explanations for this observation include a failure of miRNA post-transcriptional regulation, transcriptional silencing associated with hypermethylation of CpG island promoters and miRNA transcriptional repression by oncogenic factors. Another possibility is that the enzymes and cofactors involved in miRNA processing pathways may themselves be targets of genetic disruption, further enhancing cellular transformation. However, no loss-of-function genetic alterations in the genes encoding these proteins have been reported. Here we have identified truncating mutations in TARBP2 (TAR RNA-binding protein 2), encoding an integral component of a DICER1-containing complex, in sporadic and hereditary carcinomas with microsatellite instability. The presence of TARBP2 frameshift mutations causes diminished TRBP protein expression and a defect in the processing of miRNAs. The reintroduction of TRBP in the deficient cells restores the efficient production of miRNAs and inhibits tumor growth. Most important, the TRBP impairment is associated with a destabilization of the DICER1 protein. These results provide, for a subset of human tumors, an explanation for the observed defects in the expression of mature miRNAs.
Figures




Comment in
-
Reassessing the TARBP2 mutation rate in hereditary nonpolyposis colorectal cancer.Nat Genet. 2010 Oct;42(10):817-8; author reply 818. doi: 10.1038/ng1010-817. Nat Genet. 2010. PMID: 20877318 No abstract available.
Similar articles
-
A precursor microRNA in a cancer cell nucleus: get me out of here!Cell Cycle. 2011 Mar 15;10(6):922-5. doi: 10.4161/cc.10.6.15119. Epub 2011 Mar 15. Cell Cycle. 2011. PMID: 21346411 Free PMC article.
-
Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.J Pathol. 2013 Feb;229(3):400-9. doi: 10.1002/path.4135. J Pathol. 2013. PMID: 23132766
-
Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing.Epigenetics. 2013 May;8(5):548-58. doi: 10.4161/epi.24519. Epub 2013 Apr 17. Epigenetics. 2013. PMID: 23644875 Free PMC article.
-
miRNA processing and human cancer: DICER1 cuts the mustard.Sci Transl Med. 2011 Nov 30;3(111):111ps46. doi: 10.1126/scitranslmed.3002493. Sci Transl Med. 2011. PMID: 22133720 Review.
-
microRNA Decay: Refining microRNA Regulatory Activity.Microrna. 2016;5(3):167-174. doi: 10.2174/2211536605666161027165915. Microrna. 2016. PMID: 27804865 Review.
Cited by
-
Single-nucleotide polymorphisms of microRNA processing machinery genes are associated with risk for gastric cancer.Onco Targets Ther. 2015 Mar 4;8:567-71. doi: 10.2147/OTT.S79150. eCollection 2015. Onco Targets Ther. 2015. PMID: 25784816 Free PMC article.
-
microRNAs: short non-coding bullets of gain of function mutant p53 proteins.Oncoscience. 2014 Jun 7;1(6):427-33. doi: 10.18632/oncoscience.52. eCollection 2014. Oncoscience. 2014. PMID: 25594041 Free PMC article.
-
Mechanisms of control of microRNA biogenesis.J Biochem. 2010 Oct;148(4):381-92. doi: 10.1093/jb/mvq096. Epub 2010 Sep 9. J Biochem. 2010. PMID: 20833630 Free PMC article. Review.
-
A precursor microRNA in a cancer cell nucleus: get me out of here!Cell Cycle. 2011 Mar 15;10(6):922-5. doi: 10.4161/cc.10.6.15119. Epub 2011 Mar 15. Cell Cycle. 2011. PMID: 21346411 Free PMC article.
-
A proteomic study of TAR-RNA binding protein (TRBP)-associated factors.Cell Biosci. 2011 Feb 25;1(1):9. doi: 10.1186/2045-3701-1-9. Cell Biosci. 2011. PMID: 21711701 Free PMC article.
References
-
- Lu J, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838. - PubMed
-
- Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 2006;6:857–866. - PubMed
-
- Gaur A, et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 2007;67:2456–2468. - PubMed
-
- Saito Y, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 2006;9:435–443. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases